Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1551
Associated Banc-Corp
ASB
$5.48B
| $10.4M | ﹤0.01% |
427,044
+95,552
| +29% | +$2.15M |
2013 Q2
48 quarters
|
|
1552
Lifestance Health
LFST
$4.5B
| $10.4M | ﹤0.01% |
2,008,865
+581,732
| +41% | +$3.49M |
2022 Q1
13 quarters
|
|
|
OKLO
1553
PUT
Oklo
OKLO
$6.67B
| $10.4M | ﹤0.01% |
+185,200
| New | +$7.14M |
2025 Q2
0 quarters
|
|
|
CHX
1554
DELISTED
ChampionX
CHX
| $10.3M | ﹤0.01% |
416,479
+75,082
| +22% | +$1.89M |
2022 Q1
13 quarters
|
|
1555
Asbury Automotive
ABG
$3.16B
| $10.3M | ﹤0.01% |
43,366
+13,792
| +47% | +$3.15M |
2013 Q2
48 quarters
|
|
1556
Abercrombie & Fitch
ANF
$5.77B
| $10.3M | ﹤0.01% |
124,787
+5,550
| +5% | +$421K |
2013 Q2
48 quarters
|
|
1557
PUT
Intuit
INTU
$75.1B
| $10.3M | ﹤0.01% |
13,100
-10,900
| -45% | -$7.38M |
2024 Q4
2 quarters
|
|
1558
Amdocs
DOX
$6.07B
| $10.3M | ﹤0.01% |
113,017
-92,604
| -45% | -$8.28M |
2013 Q4
46 quarters
|
|
1559
CALL
Arcus Biosciences
RCUS
$3.11B
| $10.3M | ﹤0.01% |
+1,265,900
| New | +$10.8M |
2025 Q2
0 quarters
|
|
1560
CALL
FedEx
FDX
$68.7B
| $10.3M | ﹤0.01% |
45,100
+3,100
| +7% | +$679K |
2023 Q4
6 quarters
|
|
1561
Global Net Lease
GNL
$1.91B
| $10.2M | ﹤0.01% |
1,356,566
+175,163
| +15% | +$1.33M |
2016 Q3
35 quarters
|
|
1562
State Street SPDR S&P Regional Banking ETF
KRE
$3.61B
| $10.2M | ﹤0.01% |
172,039
-234,582
| -58% | -$13.1M |
2013 Q2
48 quarters
|
|
1563
iShares Russell 1000 Growth ETF
IWF
$130B
| $10.2M | ﹤0.01% |
96,100
+92,320
| +2,442% | +$8.83M |
2013 Q2
48 quarters
|
|
1564
Moelis & Co
MC
$4.17B
| $10.2M | ﹤0.01% |
163,657
+30,630
| +23% | +$1.72M |
2016 Q2
36 quarters
|
|
|
LNW
1565
DELISTED
Light & Wonder
LNW
| $10.2M | ﹤0.01% |
105,854
+39,963
| +61% | +$3.42M |
2016 Q2
36 quarters
|
|
1566
Axsome Therapeutics
AXSM
$9.39B
| $10.2M | ﹤0.01% |
97,490
+45,620
| +88% | +$4.83M |
2023 Q2
8 quarters
|
|
1567
Enpro
NPO
$7.04B
| $10.2M | ﹤0.01% |
53,113
-9,227
| -15% | -$1.58M |
2013 Q2
48 quarters
|
|
1568
CALL
General Motors
GM
$68.7B
| $10.1M | ﹤0.01% |
206,200
-267,100
| -56% | -$12.7M |
2022 Q4
10 quarters
|
|
1569
Advanced Energy
AEIS
$12.2B
| $10.1M | ﹤0.01% |
76,405
+23,650
| +45% | +$2.61M |
2013 Q2
48 quarters
|
|
1570
Champion Homes
SKY
$4.78B
| $10.1M | ﹤0.01% |
161,643
+51,180
| +46% | +$3.98M |
2018 Q3
27 quarters
|
|
1571
Scholar Rock
SRRK
$5.7B
| $10.1M | ﹤0.01% |
285,320
+128,949
| +82% | +$4.05M |
2018 Q3
27 quarters
|
|
1572
Novanta
NOVT
$5.65B
| $10.1M | ﹤0.01% |
78,306
+23,972
| +44% | +$2.92M |
2019 Q1
25 quarters
|
|
1573
XPO
XPO
$21.8B
| $10.1M | ﹤0.01% |
79,913
-5,793
| -7% | -$650K |
2013 Q2
48 quarters
|
|
1574
Simpson Manufacturing
SSD
$7.11B
| $10.1M | ﹤0.01% |
64,903
+12,396
| +24% | +$1.92M |
2016 Q1
37 quarters
|
|
1575
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
| $10.1M | ﹤0.01% |
600,014
-163,832
| -21% | -$2.64M |
2013 Q2
48 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.